Safety Analysis Of Premenopausal Breast Cancer Patients In Paloma‐3 Study: Is It Worth Mentioning?
Abstract
This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients.
URI
https://doi.org/10.1634/theoncologist.2016-0446https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/
http://hdl.handle.net/11655/15327